A Medical Device Daily

Aloysius Butler & Clark (AB&C; Wilmington, Delaware), a national healthcare marketing company, and KFDunn (New Castle, Delaware), a diagnostics, devices and biotech marketing communications firm, have merged to form KFDunn Life Sciences.

KFDunn will be a division of AB&C, with Kathleen Dunn serving as president of the division.

According to the companies, the merger creates one of the few life sciences marketing communications agency in the country and makes AB&C among the first agencies to integrate life science, patient care and social marketing.

The agency said its social marketing expertise was expanded in late 2006 with the addition of Shari Short, who most recently served as a partnership program coordinator for the National Cancer Institute. Short’s experience with research and program development and evaluation has equipped the agency to provide evidence-based healthcare marketing to reach patient populations and influence attitudes and behaviors.

AB&C president/CEO John Hawkins said the merger and the addition of social marketing is more than an expansion of A&C’s healthcare marketing capabilities. “For 25 years we have served hospitals, health systems, insurers and other healthcare organizations that focus primarily on healthcare delivery. By adding expertise in these areas and integrating our approaches, we can serve clients better and help them with the dramatic changes ahead.”

Over the past 18 years KFDunn has provided communication services for clinical diagnostics, radiology, molecular diagnostics, biotech, bioinformatics, genomics, proteomics, drug discovery and biomedical products; AB&C is a 36-year-old communications agency established in B2B and consumer marketing.